AI Article Synopsis

  • Infants with Infantile Neuroaxonal Dystrophy (INAD) show psychomotor stagnation and regression starting around ages 1-2, leading to severe neurological decline and early mortality, typically before age 10.
  • A case study highlights a 30-month-old boy diagnosed with INAD, exhibiting severe hypotonia, muscle weakness, and abnormal neuroimaging, although mitochondrial cytopathy was ruled out.
  • Diagnosis considers early psychomotor regression, hypotonia, muscular atrophy, and initially normal EMG findings that later reveal denervation signs, aligning with classic INAD symptoms.

Article Abstract

Introduction: Infantile neuroaxonal dystrophy (INAD), or Seitelberger disease, is a neurodegenerative disease of unknown origin which is transmitted by autosomal recessive inheritance. Clinically, it courses with psychomotor stagnation and regression that begins at the age of one or two years, associated to hypotonia with mixed clinical features (segmentary and suprasegmentary) that progresses towards spastic tetraplegia and progressive optic atrophy and dementia; this leads to death before the age of ten years. AIMS. To present the case of a 30 month old child with INAD, in whom a N acetylgalactosaminidase deficiency and mitochondrial cytopathy were ruled out.

Case Report: Male aged 30 months with an initial overall retardation, and later regression, of psychomotor acquisitions. In the physical exploration the patient displayed serious neurological involvement with mixed hypotonia, muscular hypotrophy with generalised weakness and mild bilateral horizontal nystagmus. Complementary explorations with neuroimaging revealed a slight increase in the subarachnoid space, with atrophy of the vermis and cerebellar hemispheres. Neurophysiological tests (EMG and ENG), which were initially normal, later showed signs of denervation in the EMG, and the ENG revealed a decreased amplitude of motor responses, with preservation of conduction speed. Histological tests showed the presence of axons with axoplasm expanded by the inclusion of typical tubulovascular structures.

Conclusion: The clinical features of our patient met all the criteria to satisfy a diagnosis of INAD, and he displayed a classic form of the disease. INAD must be considered when the clinician is faced with: 1. A clinical picture of stagnation and later regression of psychomotor development before the age of two years; 2. Hypotonia, muscular atrophy and initial overall areflexia, with later progression towards pyramidalism; 3. Initially normal EMG findings, with later signs of denervation; 4. Cerebellar atrophy (hemispheres and vermis); 5. Visual deficit, and 6. Histopathological proof of characteristic findings.

Download full-text PDF

Source

Publication Analysis

Top Keywords

infantile neuroaxonal
8
stagnation regression
8
age years
8
clinical features
8
regression psychomotor
8
hypotonia muscular
8
emg eng
8
initially normal
8
signs denervation
8
atrophy
5

Similar Publications

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.

Orphanet J Rare Dis

October 2024

Genomenon, Inc, 206 E. Huron St. Suite 114, Ann Arbor, MI, 48109, USA.

Article Synopsis
  • The study focuses on PLA2G6-associated neurodegeneration (PLAN), which includes three diseases with similar symptoms, particularly highlighting infantile neuroaxonal dystrophy (INAD), a condition that affects vision and motor skills from an early age.
  • Researchers estimated the genetic prevalence of PLAN using two approaches: collecting genetic variant data from various databases and analyzing literature to find additional relevant variants. They determined that the estimated prevalence ranges from 1 in 987,267 to 1 in 1,570,079 pregnancies.
  • The findings indicate a significant underdiagnosis of PLAN and suggest a higher presence of PLA2G6 variants in African and Asian populations, emphasizing the need for better diagnostic efforts
View Article and Find Full Text PDF

Infantile Neuroaxonal Dystrophy: Case Report and Review of Literature.

Medicina (Kaunas)

August 2024

Department of Biochemistry, RAK College of Medical Sciences, RAKMHSU, Ras Al-Khaimah P.O. Box 11172, United Arab Emirates.

Infantile neuroaxonal dystrophy (INAD) is a rare neurodegenerative disorder affecting 1:1,000,000 children. It results from pathogenic variants in the PLA2G6 gene located on chromosome 22q13.1.

View Article and Find Full Text PDF

Background: Despite being the second most common type of neurodegeneration with brain iron accumulation, there is limited literature on -associated neurodegeneration (PLAN) within the Asian ethnicity, particularly in the Indian context.

Methods: We conducted a retrospective observational study on patients with pathogenic/likely pathogenic variants based on exome sequencing.

Results: We identified 26 patients (22 families, 15 males) of genetically-confirmed PLAN with a median age of 22.

View Article and Find Full Text PDF

Background: Infantile neuroaxonal dystrophy (INAD) is an ultra-rare early-onset autosomal recessive neurodegenerative disorder due to variants. The clinical symptoms of INAD patients display considerable diversity, and many variants are still not thoroughly investigated in relation to their associated clinical presentations.

Case Description: A 16-month-old boy was admitted to our hospital due to regression of acquired motor and speech abilities that had persisted for 4 months.

View Article and Find Full Text PDF

Background: Preimplantation genetic testing for monogenic disorders (PGT-M) is now widely used as an effective strategy to prevent various monogenic or chromosomal diseases.

Material And Methods: In this retrospective study, couples with a family history of hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes and/or carrying the pathogenic genes underwent PGT-M to prevent children from inheriting disease-causing gene mutations from their parents and developing known genetic diseases. After PGT-M, unaffected (i.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!